Fig. 3.
Fig. 3. Expression at the mRNA level of the FV genes bearing the Leiden mutation (R506Q) and the FV defect (Y1702C), respectively, relative to a normal (Nor) FV allele. / Primers P3, P4, and P5 are used to amplify a nested FV cDNA fragment spanning exons 12 to 13 and containing a polymorphic TaqI restriction site. The 382-bp uncleaved cDNA, corresponding to the A allele of the TaqI polymorphism, marks the FV R506Q allele in subject III4 and the FV Y1702C allele in subject III5; the 346-bpTaqI restriction product, corresponding to the G allele of the TaqI polymorphism, marks the normal (Nor) FV allele in both subjects. The gene and cDNA schemes are drawn to different scales. IVS 12, intron 12.

Expression at the mRNA level of the FV genes bearing the Leiden mutation (R506Q) and the FV defect (Y1702C), respectively, relative to a normal (Nor) FV allele.

Primers P3, P4, and P5 are used to amplify a nested FV cDNA fragment spanning exons 12 to 13 and containing a polymorphic TaqI restriction site. The 382-bp uncleaved cDNA, corresponding to the A allele of the TaqI polymorphism, marks the FV R506Q allele in subject III4 and the FV Y1702C allele in subject III5; the 346-bpTaqI restriction product, corresponding to the G allele of the TaqI polymorphism, marks the normal (Nor) FV allele in both subjects. The gene and cDNA schemes are drawn to different scales. IVS 12, intron 12.

Close Modal

or Create an Account

Close Modal
Close Modal